Biohaven (BHVN) is down -9.0%, or -$4.09 to $41.50.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHVN:
- Biohaven provides updates on taldefgrobep alfa development programs
- Biohaven price target lowered to $66 from $68 at RBC Capital
- Biohaven price target raised to $75 from $55 at TD Cowen
- Biohaven reports Q3 adjusted EPS ($1.74), consensus ($1.70)
- Biohaven options imply 19.6% move in share price post-earnings